In the popular imagination, the technologically altered human being is a cross between RoboCop and the Borg.
The hardware that would make such a mating of humans, silicon chips and assorted weaponry a reality is, unfortunately, still on back order.
Many people, however, have already made a different kind of leap into the posthuman future.
Their jump is biochemical, mediated by proton-pump inhibitors, serotonin boosters and other drugs that have become permanent additives to many human bloodstreams.
Over the past half century, health-conscious, well-insured, educated people in the US and in other wealthy countries have come to take being medicated for granted.
More people shift to the pill-taking life every year, to the delight of pharmaceutical manufacturers. Indeed, drug sales suggest how willing people are to pursue better living through chemistry.
Last year, retail drug sales worldwide were US$317 billion. In the US alone, consumers spent US$163 billion on drugs. In North America, the use of drugs that affect the central nervous system, such as anti-depressants, increased 17 percent. No group has escaped. Last week the US Centers for Disease Control and Prevention reported that 10 million children took prescription medication for three months or longer in 2002, and preschoolers, another study found, are now the fastest growing group of children receiving anti-depressants.
This is a social change on the same order as the advent of computers, but one that is taking place inside the human body. Just 50 years ago, according to a report by IMS Health, a company that tracks the pharmaceutical industry, the two biggest-selling over-the-counter drugs were Bufferin and Geritol. The prescription drug business was tiny. In 1954, according to IMS, Johnson & Johnson had US$204 million in revenue. Now it is about US$36 billion. In 1954, Merck took in US$1.5 million in drug sales; in 2002, that figure was US$52 billion.
To look at it in another way, Americans take so many drugs that some researchers -- such as Dr. Christian Daughton of the Environmental Protection Agency's National Exposure Research Laboratory in Las Vegas, for example -- are worried about the effects on the environment. What does it mean if the sewers run rich with Zoloft? Or to be more precise, what might happen to fish eggs if the rivers soak up waste water with discarded and excreted pharmaceuticals and personal care products, like shampoo?
No one has the answer yet, but the idea that what runs through our collective bloodstream is a potential environmental hazard makes you look at your medicine cabinet in a different way.
In short, while the "Six Million Dollar Man" is still a fantasy, "Pharmaceutical Man" is already here, and largely unnoticed. Swallowing a pill at a business lunch is likely to elicit little curiosity. A high-powered executive who did not have blood pressure or cholesterol problems might be suspect. There are concerns about the widespread use of anti-depressants, but they do not seem to have affected sales.
In fact, the group of anti-depressants that includes Zoloft is the third biggest class of pharmaceuticals by sales in the US, totaling US$11 billion in 2003.
Drugs in the top two categories -- statins to reduce cholesterol levels and proton pump inhibitors to prevent heartburn, gastritis, ulcers and other digestive problems -- had sales of about $14 billion and US$13 billion, respectively.
Critics of the national medicine cabinet have noted that behaviors and physiological changes that were once simply aspects of life -- menopause, the inability to keep still as a child, baldness, decreasing potency in old men -- have been medicalized, turned into syndromes or diseases.
Dr. Thomas Szasz, a psychiatrist who in the 1960s defined himself as far outside the mainstream by arguing that mental illness was a myth, recently wrote a book called Pharmacracy, about the invasive rule of medicine as it defines our lives.
Last fall, the US President's Council on Bioethics issued a report called "Beyond Therapy: Biotechnology and the Pursuit of Happiness." The report included material on genetics and embryo selection, but it also addressed performance enhancement and behavioral drugs. One of its concerns was the way everything in life becomes a medical problem.
When new technologies, including drugs, come through doctors, the report said, many aspects of life become medicalized, raising concerns that "the pursuit of happiness and self-perfection would become part of the doctor's business."
The report also catalogued "other aspects of human life that formerly had little to do with doctors and hospitals: childbirth, infertility, sexual mores and practices, aspects of criminal behavior, alcoholism, abnormal behavior, anxiety, stress, dementia, old age, death, grief and mourning."
One might argue that any extension of medicine should be welcome. The prevention of heart attacks is obviously a worthy effort. Anti-depressants can ease anguish, which for many people who take them is overwhelming. In many countries of the world, people would jump at the chance to worry about having too much medicine; they don't have nearly enough of it.
Yet some of the new miracles of the pharmaceutical industry are not intended to save lives, but to improve and prolong them.
Ana-Maria Zaugg, vice president of corporate strategic planning for IMS Health, said that there were two streams of change in pharmaceutical research and use.
Acute care is giving way to chronic or preventive care -- managing cholesterol levels rather than treating heart attacks, for example. At the same time, disease treatment is being extended to treatment whose goal is to increase well-being.
Drugs for baldness, incontinence, sexual performance and the effects of menopause may be included in the latter category. Both trends are expected to increase, Zaugg said.
Some areas that she is confident will grow are drugs to improve male sexual performance, anti-Alzheimer's drugs, and drugs for incontinence and osteoporosis. If new psychostimulants and anti-obesity drugs appear in the future, she said, they will quickly take off. Compounds that increase intelligence and greatly improve memory will undoubtedly be best sellers as well.
Whether or not the growing use of drugs has altered our essential humanity, there is now almost no bodily system that cannot be adjusted by them.
Blood, respiration, the nervous system, hormonal regulation, muscles and bones, the cardiovascular system, reproduction, sexuality -- drugs are available to nudge them all in one direction or the other. It is not unusual for someone to begin the day with a cocktail of anti-depressants, statins and blood pressure medications.
One problem, of course, is that it is the well-off and the well educated who are most likely to take advantage of the many drugs available. Another is that need can be manufactured by
advertising.
Even children know from television that if you are sad and worried, there is a pill for you. If you have heartburn there is a pill for you. It is a lot harder to find out that there are other ways to feel better, physically and emotionally, than taking drugs.
In late October of 1873 the government of Japan decided against sending a military expedition to Korea to force that nation to open trade relations. Across the government supporters of the expedition resigned immediately. The spectacle of revolt by disaffected samurai began to loom over Japanese politics. In January of 1874 disaffected samurai attacked a senior minister in Tokyo. A month later, a group of pro-Korea expedition and anti-foreign elements from Saga prefecture in Kyushu revolted, driven in part by high food prices stemming from poor harvests. Their leader, according to Edward Drea’s classic Japan’s Imperial Army, was a samurai
The following three paragraphs are just some of what the local Chinese-language press is reporting on breathlessly and following every twist and turn with the eagerness of a soap opera fan. For many English-language readers, it probably comes across as incomprehensibly opaque, so bear with me briefly dear reader: To the surprise of many, former pop singer and Democratic Progressive Party (DPP) ex-lawmaker Yu Tien (余天) of the Taiwan Normal Country Promotion Association (TNCPA) at the last minute dropped out of the running for committee chair of the DPP’s New Taipei City chapter, paving the way for DPP legislator Su
It’s hard to know where to begin with Mark Tovell’s Taiwan: Roads Above the Clouds. Having published a travelogue myself, as well as having contributed to several guidebooks, at first glance Tovell’s book appears to inhabit a middle ground — the kind of hard-to-sell nowheresville publishers detest. Leaf through the pages and you’ll find them suffuse with the purple prose best associated with travel literature: “When the sun is low on a warm, clear morning, and with the heat already rising, we stand at the riverside bike path leading south from Sanxia’s old cobble streets.” Hardly the stuff of your
Located down a sideroad in old Wanhua District (萬華區), Waley Art (水谷藝術) has an established reputation for curating some of the more provocative indie art exhibitions in Taipei. And this month is no exception. Beyond the innocuous facade of a shophouse, the full three stories of the gallery space (including the basement) have been taken over by photographs, installation videos and abstract images courtesy of two creatives who hail from the opposite ends of the earth, Taiwan’s Hsu Yi-ting (許懿婷) and Germany’s Benjamin Janzen. “In 2019, I had an art residency in Europe,” Hsu says. “I met Benjamin in the lobby